CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung
Cancer Research and Treatment. 2007;39(3):134-137.   Published online 2007 September 30    DOI: https://doi.org/10.4143/crt.2007.39.3.134

Excel Download

A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report
Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung
Cancer Research and Treatment. 2007;39(3):134   Crossref logo
Link1 Link2
Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer
Mohamed I. El-sayed, Doaa W. Maximous, Madeha M. Zakhary, Nabiel N. H. Mikhail
ISRN Oncology. 2012;2012:1-8   Crossref logo
Link1 Link2 Link3
Locally Advanced Breast Cancer (LABC) and Neoadjuvant Chemotherapy
Breast Cancer Imaging. 2008;224-301   Crossref logo
Link1 Link2
Neoadjuvant chemotherapy carboplatin – taxane response in locally advanced triple negative breast cancer patients in relation to molecular biomarkers
L.M. Sad, S. Younis, M. Abd El Hak
Annals of Oncology. 2016;27:vi92   Crossref logo
Link1 Link2 Link3
Which is Your Choice?; Neoadjuvant Adriamycin and Doxetaxel (AD) Versus Adriamycin, Cyclophosphamide and Paclitaxel(AC-T) in Locally Advanced Breast Cancer
S.Y. Kang, K.S. Kim
Annals of Oncology. 2012;23:ix135   Crossref logo
Link1 Link2
Neoadjuvant Gemcitabine-Taxane Chemotherapy for Radiation-Induced Angiosarcoma of the Breast: A Case Report
Angel Arnaout, Dawn M. Wedman, Samy El-Sayed, Virbala Acharya, Shilpa Lad
The Breast Journal. 2012;18(3):276-278   Crossref logo
Link1 Link2
CD24 Polymorphisms Cannot Predict Pathologic Complete Response to Anthracycline- and Taxane-Based Neoadjuvant Chemotherapy in Breast Cancer
Xin Zhou
Clinical Breast Cancer. 2014;14(2):e33-e40   Crossref logo
Link1 Link2
Which is Your Choice? Neoadjuvant Adriamycin and Doxetaxel (AD) Versus Adriamycin, Cyclophosphamide and Paclitaxel (AC-T) in Locally Advanced Breast Cancer
S.Y. Kang, J.-H. Choi, H.W. Lee, M. Ahn, K.S. Kim
Annals of Oncology. 2012;23:xi127   Crossref logo
Link1 Link2
433 PUBLICATION A phase II study of neoadjuvant chemotherapy (NC) with taxotere, adriamycin and cyclophosphamide (TAC) in locally advanced breast cancer (LABC)
European Journal of Cancer Supplements. 2005;3(2):122   Crossref logo
Link1 Link2
Neoadjuvant chemotherapy in locally advanced breast carcinoma
I. Yarom, M. Steiner, R. Borovik, I. Rabinovich
European Journal of Cancer. 1993;29:S79   Crossref logo
Link1 Link2
This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.